| Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications | Clinical Pharmacology and Therapeutics | 2014 | 99 |
| Treatment for calcium channel blocker poisoning: a systematic review | Clinical Toxicology | 2014 | 97 |
| Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias | Parkinsonism and Related Disorders | 2014 | 80 |
| Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis | Hepatology | 2014 | 72 |
| Modeling dyskinesia in animal models of Parkinson disease | Experimental Neurology | 2014 | 66 |
| Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease | Neuropharmacology | 2014 | 50 |
| Health-related empowerment in cancer: validity of scales from the Health Education Impact Questionnaire | Cancer | 2014 | 48 |
| Sudden cardiac death and obesity | Expert Review of Cardiovascular Therapy | 2014 | 47 |
| PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program | Atherosclerosis | 2014 | 44 |
| Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice | Neurobiology of Aging | 2014 | 41 |
| Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation | Journal of Lipid Research | 2014 | 38 |
| Practical assessment of delirium in palliative care | Journal of Pain and Symptom Management | 2014 | 38 |
| Increased LINGO1 in the cerebellum of essential tremor patients | Movement Disorders | 2014 | 35 |
| Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer | International Journal of Cancer | 2014 | 35 |
| AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys | Parkinsonism and Related Disorders | 2014 | 35 |
| Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates | Frontiers in Neurology | 2014 | 27 |
| Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion | Molecular Pharmaceutics | 2014 | 26 |
| Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway | Clinical Cancer Research | 2014 | 25 |
| Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides | Atherosclerosis | 2014 | 25 |
| Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action | Journal of Neurosurgery | 2014 | 24 |
| Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer | Clinical Cancer Research | 2014 | 23 |
| Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys | Neuropharmacology | 2014 | 23 |
| Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolism | Molecular Pharmacology | 2014 | 18 |
| Health economics and surgical treatment for Parkinson's disease in a world perspective: results from an international survey | Stereotactic and Functional Neurosurgery | 2014 | 18 |
| Influence of polyunsaturated fatty acids on blood pressure, resting heart rate and heart rate variability among French Polynesians | Journal of the American College of Nutrition | 2014 | 15 |
